DG
Daniil Gataulin Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
71
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
84.6%
Neutral
15.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $7 |
302%
upside
| 2 | +19% |
0
%
| 5 Mar ‘26 21 hours ago |
|
|
|
Buy
Maintained
| $15 |
274%
upside
| 1 | -0.59% |
0
%
| 5 Mar ‘26 22 hours ago |
|
|
|
Buy
Maintained
| $29 |
84%
upside
| 1 | +31% |
0
%
| 4 Mar ‘26 yesterday |
|
|
|
Buy
Maintained
| $16 |
50%
upside
| 1 | +13% |
0
%
| 3 Mar ‘26 2 days ago |
|
|
|
Neutral
Maintained
| $1 |
132%
upside
| 2 | – |
–
| 18 Feb ‘26 15 days ago |
|
|
|
Buy
Maintained
| $21 |
103%
upside
| 2 | +4.8% |
0
%
| 18 Feb ‘26 16 days ago |
|
|
|
Buy
Maintained
| $50 |
473%
upside
| 2 | +4.9% |
0
%
| 10 Feb ‘26 23 days ago |
|
|
|
Buy
Initiated
| $16 |
195%
upside
| 1 | +4.6% |
0
%
| 23 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $19 |
96%
upside
| 1 | -3.8% |
0
%
| 23 Dec ‘25 2 months ago |
|